Randa G. Hanna-Sawires

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Bert A. Bonsing · 5 shared papers, 2020–2025 · strength 0.67
   • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
2. Wilma E. Mesker · 4 shared papers, 2020–2022 · strength 0.48
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
3. Rob A.E.M. Tollenaar · 4 shared papers, 2020–2022 · strength 0.48
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
4. Manfred Wuhrer · 3 shared papers, 2020–2022 · strength 0.36
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
   • Paper Serum N-Glycome analysis reveals pancreatic cancer disease signatures. DOI 10.1002/cam4.3439↗
5. Yuri E. M. van der Burgt · 3 shared papers, 2020–2022 · strength 0.36
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
   • Paper Serum N-Glycome analysis reveals pancreatic cancer disease signatures. DOI 10.1002/cam4.3439↗
6. Jesse V. Groen · 2 shared papers, 2021–2025 · strength 0.31
   • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
   • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
7. J. Sven D. Mieog · 2 shared papers, 2021–2025 · strength 0.31
   • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
   • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
8. Monique Esther van Leerdam · 2 shared papers, 2021–2022 · strength 0.26
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
9. Hans F. A. Vasen · 2 shared papers, 2021–2022 · strength 0.26
   • Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
   • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
10. Gerda C. M. Vreeker · 2 shared papers, 2020–2022 · strength 0.22
    • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
    • Paper Serum N-Glycome analysis reveals pancreatic cancer disease signatures. DOI 10.1002/cam4.3439↗
11. Nick van Es · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
12. Jeroen T. Buijs · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
13. Hanneke W. Wilmink · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
14. Floris T.M. Bosch · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
15. Izaak Quintus Molenaar · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
16. Joanne Verheij · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
17. Frederike Dijk · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
18. Marc G. Besselink · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
19. Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
20. Maarten F. Bijlsma · 1 shared paper, 2025 · strength 0.19
    • Paper Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma. DOI 10.1016/j.thromres.2024.109240↗
21. Alexander L. Vahrmeijer · 1 shared paper, 2021 · strength 0.12
    • Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
22. Brechtje D.M. Koopmann · 1 shared paper, 2022 · strength 0.12
    • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
23. Iris J. M. Levink · 1 shared paper, 2022 · strength 0.12
    • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
24. Isaura S. Ibrahim · 1 shared paper, 2022 · strength 0.12
    • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
25. Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.12
    • Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.